Tivic Health Systems Price to Book Ratio 2020-2025 | TIVC
Historical price to book ratio values for Tivic Health Systems (TIVC) over the last 10 years. The current price to book ratio for Tivic Health Systems as of November 14, 2025 is 0.54.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Tivic Health Systems Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-11-14 | 1.91 | 0.50 | |
| 2025-06-30 | 4.15 | $3.82 | 1.09 |
| 2025-03-31 | 2.56 | $4.30 | 0.60 |
| 2024-12-31 | 5.88 | $4.55 | 1.29 |
| 2024-09-30 | 4.25 | $7.72 | 0.55 |
| 2024-06-30 | 6.63 | $11.53 | 0.58 |
| 2024-03-31 | 21.25 | $24.85 | 0.86 |
| 2023-12-31 | 30.60 | $41.51 | 0.74 |
| 2023-09-30 | 29.41 | $66.87 | 0.44 |
| 2023-06-30 | 180.20 | $181.14 | 0.99 |
| 2023-03-31 | 256.70 | $298.27 | 0.86 |
| 2022-12-31 | 1088.00 | $637.90 | 1.71 |
| 2022-09-30 | 2465.00 | $1,014.32 | 2.43 |
| 2022-06-30 | 3315.00 | $1,447.12 | 2.29 |
| 2022-03-31 | 2737.00 | $1,941.86 | 1.41 |
| 2021-12-31 | 6596.00 | $2,323.30 | 2.84 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.002B | $0.001B |
| Tivic Health Systems Inc. is a commercial-phase healthtech company advancing bioelectronic medicine to deliver non-invasive solutions which treat disease, increase wellness and improve lives. Its first product includes ClearUP(R). Tivic Health Systems Inc. is based in MENLO PARK, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.084B | 58.67 |
| Tempus AI (TEM) | United States | $11.897B | 0.00 |
| Doximity (DOCS) | United States | $9.342B | 38.47 |
| Hims & Hers Health (HIMS) | United States | $8.418B | 68.48 |
| IRhythm Technologies (IRTC) | United States | $5.504B | 0.00 |
| Hinge Health (HNGE) | United States | $3.224B | 0.00 |
| Privia Health (PRVA) | United States | $2.884B | 180.38 |
| Inspire Medical Systems (INSP) | United States | $2.509B | 41.51 |
| Heartflow (HTFL) | United States | $2.383B | 0.00 |
| 10x Genomics (TXG) | United States | $1.978B | 0.00 |
| Enovis (ENOV) | United States | $1.715B | 9.01 |
| Omnicell (OMCL) | United States | $1.576B | 32.22 |
| Azenta (AZTA) | United States | $1.364B | 59.50 |
| Phreesia (PHR) | United States | $1.304B | 0.00 |
| Schrodinger (SDGR) | United States | $1.299B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.276B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.900B | 0.00 |
| Claritev (CTEV) | United States | $0.715B | 0.00 |
| Talkspace (TALK) | United States | $0.538B | 108.33 |
| Butterfly Network (BFLY) | United States | $0.536B | 0.00 |
| Veradigm (MDRX) | United States | $0.523B | 0.00 |
| Standard BioTools (LAB) | United States | $0.477B | 0.00 |
| Evolent Health (EVH) | United States | $0.466B | 0.00 |
| Carlsmed (CARL) | United States | $0.349B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.348B | 0.00 |
| TruBridge (TBRG) | United States | $0.306B | 14.05 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.239B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.212B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.200B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.172B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.170B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.160B | 0.00 |
| CareCloud (CCLD) | United States | $0.133B | 7.28 |
| EUDA Health Holdings (EUDA) | Singapore | $0.110B | 0.00 |
| Outset Medical (OM) | United States | $0.085B | 0.00 |
| American Well (AMWL) | United States | $0.066B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.066B | 0.00 |
| Pulmonx (LUNG) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.049B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Precipio (PRPO) | United States | $0.031B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.025B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.012B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |